The lyophilized canine-specific albumin utilized in this study was provided by Animal Blood Resources International, Dixon, CA, USA. Dr. Powell is an assistant editor for the journal but did not participate in the peer review process other than as an author. The authors declare no other conflict of interest.
The use of canine-specific albumin in dogs with septic peritonitis
Article first published online: 6 DEC 2012
© Veterinary Emergency and Critical Care Society 2012
Journal of Veterinary Emergency and Critical Care
Volume 22, Issue 6, pages 631–639, December 2012
How to Cite
Craft, E. M. and Powell, L. L. (2012), The use of canine-specific albumin in dogs with septic peritonitis. Journal of Veterinary Emergency and Critical Care, 22: 631–639. doi: 10.1111/j.1476-4431.2012.00819.x
Presented in part at the 16th International Veterinary Emergency and Critical Care Symposium, San Antonio, TX, September 2010.
- Issue published online: 6 DEC 2012
- Article first published online: 6 DEC 2012
- Manuscript Accepted: 29 SEP 2012
- Manuscript Received: 18 AUG 2011
- Animal Blood Resources International
- colloid osmotic pressure;
- fluid resuscitation;
- natural colloids;
To assess changes in serum albumin concentration (ALB), colloid osmotic pressure (COP), and Doppler blood pressure (DBP) following transfusion of 5% lyophilized canine-specific albumin (CSA) in hypoalbuminemic dogs following surgical source control for septic peritonitis.
Prospective randomized clinical trial November 2009 – November 2010.
University teaching hospital.
Fourteen client-owned dogs with hypoalbuminemia (<27 g/L [2.7 g/dL]) following surgical source control for septic peritonitis.
Dogs were randomized to clinician-directed therapy (CDT) and CSA groups. Dogs enrolled in the CSA group received 800 mg/kg of CSA within 24 hours following surgical intervention.
Measurements and Main Results
At enrollment, ALB, COP, and DBP were not different between groups. ALB, COP, and DBP were significantly increased in the CSA group 2 hours following completion of the transfusion compared with the CDT group (P = 0.0234, 0.0078, 0.0156, respectively). In comparison to the CDT group, there was a significant change in ALB in the CSA group 24 hours after transfusion (P = 0.0039), but no difference in COP (P = 0.3914) or DBP (P = 0.5145). ALB was significantly higher in the CSA group at 24 hours compared with the CDT group (P = 0.0367) At the time of death or discharge, there was no difference between groups regarding ALB, COP, or DBP, but an association between ALB and survival was identified (P = 0.0273). One dog experienced tachypnea during transfusion of CSA; this dog died of unknown respiratory causes 120 hours after transfusion.
The administration of CSA in dogs with septic peritonitis results in an increase in ALB, COP, and DBP 2 hours after administration. An increase in ALB persisted at 24 hours compared with a CDT group. Administration of this product was not associated with owner-reported delayed adverse events in this population of dogs.